Relating mutational signature exposures to clinical data in cancers via signeR 2.0 (2023)
Drummond, Rodrigo Duarte; Defelicibus, Alexandre; Meyenberg, Mathilde; Valieris, Renan; Dias Neto, Emmanuel; Mitrowsky, Rafael Andres Rosales 
; Silva, Israel Tojal da
Fonte: BMC Bioinformatics. Unidade: FFCLRP
Assuntos: ALGORITMOS, INFERÊNCIA BAYESIANA, MUTAÇÃO, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DRUMMOND, Rodrigo Duarte et al. Relating mutational signature exposures to clinical data in cancers via signeR 2.0. BMC Bioinformatics, v. 24, n. 1, p. 1-11, 2023Tradução . . Disponível em: https://doi.org/10.1186/s12859-023-05550-3. Acesso em: 09 nov. 2025.APA
Drummond, R. D., Defelicibus, A., Meyenberg, M., Valieris, R., Dias Neto, E., Mitrowsky, R. A. R., & Silva, I. T. da. (2023). Relating mutational signature exposures to clinical data in cancers via signeR 2.0. BMC Bioinformatics, 24( 1), 1-11. doi:10.1186/s12859-023-05550-3NLM
Drummond RD, Defelicibus A, Meyenberg M, Valieris R, Dias Neto E, Mitrowsky RAR, Silva IT da. Relating mutational signature exposures to clinical data in cancers via signeR 2.0 [Internet]. BMC Bioinformatics. 2023 ; 24( 1): 1-11.[citado 2025 nov. 09 ] Available from: https://doi.org/10.1186/s12859-023-05550-3Vancouver
Drummond RD, Defelicibus A, Meyenberg M, Valieris R, Dias Neto E, Mitrowsky RAR, Silva IT da. Relating mutational signature exposures to clinical data in cancers via signeR 2.0 [Internet]. BMC Bioinformatics. 2023 ; 24( 1): 1-11.[citado 2025 nov. 09 ] Available from: https://doi.org/10.1186/s12859-023-05550-3
